Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome

Dan Li(Wuhan University), Zhi Zeng(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Oxidative Medicine and Cellular Longevity
January 1, 2021
10.1155/2021/5175581
Cited by 19

Related Papers

Sphingosine Kinase 1 and Cancer: A Systematic Review and Meta-Analysis
|PLoS ONE|2014|85
Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1α expression through the PI3K-dependent pathway
|International Journal of Molecular Medicine|2015|36
Activation of <scp>PI3K/Akt/mTOR</scp> signaling pathway triggered by <scp>PTEN</scp> downregulation in the pathogenesis of <scp>C</scp>rohn's disease
|Journal of Digestive Diseases|2013|26
Anti‑Nogo‑A antibody promotes brain function recovery after cardiopulmonary resuscitation in rats by reducing apoptosis
|Molecular Medicine Reports|2019|8